Evidence map›Paper›PMID 40407644›Full record

ArticleInfectious disease reports2025

Humoral and Cell-Mediated Immunity Against SARS-CoV-2 in Healthcare Personnel Who Received Multiple mRNA Vaccines: A 4-Year Observational Study.

Hideaki Kato, Kaori Sano, Kei Miyakawa, Takayuki Kurosawa, Kazuo Horikawa, Yayoi Kimura, Atsushi Goto, Akihide Ryo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious disease reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hideaki KatoInfection Prevention and Control Department, Yokohama City University Hospital, Yokohama 236-0004, Japan.ORCID 0000-0002-7853-5721
Kaori SanoInfluenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Musashimurayama 208-0011, Japan.
Kei MiyakawaInfluenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Musashimurayama 208-0011, Japan.
Takayuki KurosawaClinical Laboratory Department, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Kazuo HorikawaEmerging Infectious Diseases Research Center, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Yayoi KimuraEmerging Infectious Diseases Research Center, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Atsushi GotoEmerging Infectious Diseases Research Center, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Akihide RyoDepartment of Bioinformatics and Integrative Omics, National Institute of Infectious Diseases, Japan Institute for Health Security, Musashimurayama 208-0011, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

50% neutralizing titerantibody divergencecell-mediated immunityCOVID-19ELISpothumoral immunityinterferon-gamma releasing assayoriginal antigenic sinSARS-CoV-2updated vaccine

Identifiers

PMID40407644
PMCPMC12101388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.